nodes	percent_of_prediction	percent_of_DWPC	metapath
Dyphylline—Caffeine—PIK3CD—pancreatic cancer	0.0161	0.361	CrCbGaD
Dyphylline—Caffeine—PIK3CB—pancreatic cancer	0.0161	0.361	CrCbGaD
Dyphylline—Caffeine—PIK3CA—pancreatic cancer	0.0124	0.279	CrCbGaD
Dyphylline—Tachypnoea—Gemcitabine—pancreatic cancer	0.00999	0.0811	CcSEcCtD
Dyphylline—Haematemesis—Erlotinib—pancreatic cancer	0.00707	0.0574	CcSEcCtD
Dyphylline—Haematemesis—Sunitinib—pancreatic cancer	0.00612	0.0497	CcSEcCtD
Dyphylline—Abdominal pain upper—Sunitinib—pancreatic cancer	0.00282	0.0229	CcSEcCtD
Dyphylline—Hyperglycaemia—Sunitinib—pancreatic cancer	0.00241	0.0195	CcSEcCtD
Dyphylline—Haematemesis—Epirubicin—pancreatic cancer	0.00235	0.0191	CcSEcCtD
Dyphylline—Irritability—Fluorouracil—pancreatic cancer	0.00232	0.0189	CcSEcCtD
Dyphylline—Flushing—Tamoxifen—pancreatic cancer	0.00231	0.0188	CcSEcCtD
Dyphylline—Ventricular arrhythmia—Epirubicin—pancreatic cancer	0.00221	0.0179	CcSEcCtD
Dyphylline—Albuminuria—Epirubicin—pancreatic cancer	0.00219	0.0178	CcSEcCtD
Dyphylline—Haematemesis—Doxorubicin—pancreatic cancer	0.00218	0.0177	CcSEcCtD
Dyphylline—Ventricular arrhythmia—Doxorubicin—pancreatic cancer	0.00204	0.0166	CcSEcCtD
Dyphylline—Albuminuria—Doxorubicin—pancreatic cancer	0.00202	0.0164	CcSEcCtD
Dyphylline—Flushing—Sunitinib—pancreatic cancer	0.00198	0.0161	CcSEcCtD
Dyphylline—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.00193	0.0157	CcSEcCtD
Dyphylline—Haematuria—Gemcitabine—pancreatic cancer	0.00182	0.0148	CcSEcCtD
Dyphylline—Shock—Erlotinib—pancreatic cancer	0.00172	0.014	CcSEcCtD
Dyphylline—Flushing—Irinotecan—pancreatic cancer	0.00163	0.0133	CcSEcCtD
Dyphylline—Convulsion—Sunitinib—pancreatic cancer	0.00161	0.0131	CcSEcCtD
Dyphylline—Abdominal pain upper—Docetaxel—pancreatic cancer	0.00161	0.013	CcSEcCtD
Dyphylline—Insomnia—Tamoxifen—pancreatic cancer	0.0016	0.013	CcSEcCtD
Dyphylline—Insomnia—Erlotinib—pancreatic cancer	0.00159	0.0129	CcSEcCtD
Dyphylline—Shock—Sunitinib—pancreatic cancer	0.00149	0.0121	CcSEcCtD
Dyphylline—Insomnia—Sunitinib—pancreatic cancer	0.00137	0.0111	CcSEcCtD
Dyphylline—Convulsion—Fluorouracil—pancreatic cancer	0.00127	0.0103	CcSEcCtD
Dyphylline—Shock—Irinotecan—pancreatic cancer	0.00123	0.00998	CcSEcCtD
Dyphylline—Diarrhoea—Tamoxifen—pancreatic cancer	0.00121	0.00984	CcSEcCtD
Dyphylline—Diarrhoea—Erlotinib—pancreatic cancer	0.0012	0.00974	CcSEcCtD
Dyphylline—Tachycardia—Fluorouracil—pancreatic cancer	0.00117	0.00949	CcSEcCtD
Dyphylline—Hypotension—Irinotecan—pancreatic cancer	0.00117	0.00948	CcSEcCtD
Dyphylline—Hypotension—Gemcitabine—pancreatic cancer	0.00114	0.00924	CcSEcCtD
Dyphylline—Insomnia—Irinotecan—pancreatic cancer	0.00113	0.00918	CcSEcCtD
Dyphylline—Flushing—Docetaxel—pancreatic cancer	0.00113	0.00916	CcSEcCtD
Dyphylline—Vomiting—Tamoxifen—pancreatic cancer	0.00113	0.00914	CcSEcCtD
Dyphylline—Hypotension—Fluorouracil—pancreatic cancer	0.00112	0.00908	CcSEcCtD
Dyphylline—Vomiting—Erlotinib—pancreatic cancer	0.00111	0.00905	CcSEcCtD
Dyphylline—Headache—Tamoxifen—pancreatic cancer	0.00111	0.00901	CcSEcCtD
Dyphylline—Insomnia—Gemcitabine—pancreatic cancer	0.0011	0.00894	CcSEcCtD
Dyphylline—Headache—Erlotinib—pancreatic cancer	0.0011	0.00891	CcSEcCtD
Dyphylline—Abdominal pain upper—Epirubicin—pancreatic cancer	0.00108	0.00879	CcSEcCtD
Dyphylline—Insomnia—Fluorouracil—pancreatic cancer	0.00108	0.00879	CcSEcCtD
Dyphylline—Nausea—Tamoxifen—pancreatic cancer	0.00105	0.00854	CcSEcCtD
Dyphylline—Nausea—Erlotinib—pancreatic cancer	0.00104	0.00845	CcSEcCtD
Dyphylline—Diarrhoea—Sunitinib—pancreatic cancer	0.00104	0.00843	CcSEcCtD
Dyphylline—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.001	0.00814	CcSEcCtD
Dyphylline—Vomiting—Sunitinib—pancreatic cancer	0.000965	0.00783	CcSEcCtD
Dyphylline—Headache—Sunitinib—pancreatic cancer	0.000951	0.00772	CcSEcCtD
Dyphylline—Palpitations—Docetaxel—pancreatic cancer	0.000936	0.0076	CcSEcCtD
Dyphylline—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000924	0.00751	CcSEcCtD
Dyphylline—Convulsion—Docetaxel—pancreatic cancer	0.000917	0.00745	CcSEcCtD
Dyphylline—Nausea—Sunitinib—pancreatic cancer	0.000901	0.00732	CcSEcCtD
Dyphylline—Haematuria—Epirubicin—pancreatic cancer	0.000871	0.00707	CcSEcCtD
Dyphylline—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000855	0.00694	CcSEcCtD
Dyphylline—Diarrhoea—Irinotecan—pancreatic cancer	0.000855	0.00694	CcSEcCtD
Dyphylline—Shock—Docetaxel—pancreatic cancer	0.00085	0.0069	CcSEcCtD
Dyphylline—Tachycardia—Docetaxel—pancreatic cancer	0.000843	0.00685	CcSEcCtD
Dyphylline—Diarrhoea—Gemcitabine—pancreatic cancer	0.000833	0.00676	CcSEcCtD
Dyphylline—Diarrhoea—Fluorouracil—pancreatic cancer	0.000819	0.00665	CcSEcCtD
Dyphylline—Hypotension—Docetaxel—pancreatic cancer	0.000807	0.00655	CcSEcCtD
Dyphylline—Haematuria—Doxorubicin—pancreatic cancer	0.000806	0.00654	CcSEcCtD
Dyphylline—Vomiting—Irinotecan—pancreatic cancer	0.000795	0.00645	CcSEcCtD
Dyphylline—Headache—Irinotecan—pancreatic cancer	0.000783	0.00636	CcSEcCtD
Dyphylline—Insomnia—Docetaxel—pancreatic cancer	0.000781	0.00634	CcSEcCtD
Dyphylline—Vomiting—Gemcitabine—pancreatic cancer	0.000774	0.00628	CcSEcCtD
Dyphylline—Headache—Gemcitabine—pancreatic cancer	0.000763	0.00619	CcSEcCtD
Dyphylline—Flushing—Epirubicin—pancreatic cancer	0.000761	0.00618	CcSEcCtD
Dyphylline—Vomiting—Fluorouracil—pancreatic cancer	0.000761	0.00618	CcSEcCtD
Dyphylline—Headache—Fluorouracil—pancreatic cancer	0.00075	0.00609	CcSEcCtD
Dyphylline—Nausea—Irinotecan—pancreatic cancer	0.000742	0.00603	CcSEcCtD
Dyphylline—Nausea—Gemcitabine—pancreatic cancer	0.000723	0.00587	CcSEcCtD
Dyphylline—Nausea—Fluorouracil—pancreatic cancer	0.000711	0.00577	CcSEcCtD
Dyphylline—Flushing—Doxorubicin—pancreatic cancer	0.000704	0.00572	CcSEcCtD
Dyphylline—Agitation—Epirubicin—pancreatic cancer	0.000656	0.00533	CcSEcCtD
Dyphylline—Palpitations—Epirubicin—pancreatic cancer	0.000631	0.00512	CcSEcCtD
Dyphylline—Convulsion—Epirubicin—pancreatic cancer	0.000619	0.00502	CcSEcCtD
Dyphylline—Agitation—Doxorubicin—pancreatic cancer	0.000607	0.00493	CcSEcCtD
Dyphylline—Diarrhoea—Docetaxel—pancreatic cancer	0.000591	0.0048	CcSEcCtD
Dyphylline—Palpitations—Doxorubicin—pancreatic cancer	0.000584	0.00474	CcSEcCtD
Dyphylline—Shock—Epirubicin—pancreatic cancer	0.000573	0.00465	CcSEcCtD
Dyphylline—Convulsion—Doxorubicin—pancreatic cancer	0.000572	0.00465	CcSEcCtD
Dyphylline—Tachycardia—Epirubicin—pancreatic cancer	0.000569	0.00462	CcSEcCtD
Dyphylline—Vomiting—Docetaxel—pancreatic cancer	0.000549	0.00446	CcSEcCtD
Dyphylline—Hypotension—Epirubicin—pancreatic cancer	0.000545	0.00442	CcSEcCtD
Dyphylline—Headache—Docetaxel—pancreatic cancer	0.000541	0.00439	CcSEcCtD
Dyphylline—Shock—Doxorubicin—pancreatic cancer	0.000531	0.00431	CcSEcCtD
Dyphylline—Insomnia—Epirubicin—pancreatic cancer	0.000527	0.00428	CcSEcCtD
Dyphylline—Tachycardia—Doxorubicin—pancreatic cancer	0.000526	0.00427	CcSEcCtD
Dyphylline—Nausea—Docetaxel—pancreatic cancer	0.000513	0.00417	CcSEcCtD
Dyphylline—Hypotension—Doxorubicin—pancreatic cancer	0.000504	0.00409	CcSEcCtD
Dyphylline—Insomnia—Doxorubicin—pancreatic cancer	0.000488	0.00396	CcSEcCtD
Dyphylline—Diarrhoea—Epirubicin—pancreatic cancer	0.000399	0.00324	CcSEcCtD
Dyphylline—Vomiting—Epirubicin—pancreatic cancer	0.000371	0.00301	CcSEcCtD
Dyphylline—Diarrhoea—Doxorubicin—pancreatic cancer	0.000369	0.003	CcSEcCtD
Dyphylline—Headache—Epirubicin—pancreatic cancer	0.000365	0.00296	CcSEcCtD
Dyphylline—Nausea—Epirubicin—pancreatic cancer	0.000346	0.00281	CcSEcCtD
Dyphylline—Vomiting—Doxorubicin—pancreatic cancer	0.000343	0.00278	CcSEcCtD
Dyphylline—Headache—Doxorubicin—pancreatic cancer	0.000338	0.00274	CcSEcCtD
Dyphylline—Nausea—Doxorubicin—pancreatic cancer	0.00032	0.0026	CcSEcCtD
Dyphylline—PDE7B—Signaling Pathways—EGFR—pancreatic cancer	0.000147	0.000176	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—HIF1A—pancreatic cancer	0.000145	0.000175	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—PIK3CD—pancreatic cancer	0.000145	0.000174	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—TSC2—pancreatic cancer	0.000145	0.000174	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—KDR—pancreatic cancer	0.000144	0.000173	CbGpPWpGaD
Dyphylline—PDE4C—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000144	0.000173	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—PIK3CG—pancreatic cancer	0.000144	0.000173	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—NRAS—pancreatic cancer	0.000144	0.000173	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—HIF1A—pancreatic cancer	0.000144	0.000172	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—TSC2—pancreatic cancer	0.000143	0.000172	CbGpPWpGaD
Dyphylline—PDE4C—Signaling by GPCR—KRAS—pancreatic cancer	0.000142	0.000171	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—EGF—pancreatic cancer	0.000142	0.000171	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—APOE—pancreatic cancer	0.000142	0.00017	CbGpPWpGaD
Dyphylline—ADORA2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000141	0.00017	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000141	0.00017	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—APOE—pancreatic cancer	0.00014	0.000168	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—NOTCH1—pancreatic cancer	0.00014	0.000168	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—MYC—pancreatic cancer	0.000139	0.000167	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—TGFB1—pancreatic cancer	0.000139	0.000167	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—KDR—pancreatic cancer	0.000139	0.000167	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—KRAS—pancreatic cancer	0.000138	0.000166	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000137	0.000165	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—KDR—pancreatic cancer	0.000137	0.000165	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—SMAD4—pancreatic cancer	0.000137	0.000165	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—PIK3CG—pancreatic cancer	0.000137	0.000164	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—NRAS—pancreatic cancer	0.000137	0.000164	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—EGFR—pancreatic cancer	0.000136	0.000164	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—NOTCH1—pancreatic cancer	0.000136	0.000163	CbGpPWpGaD
Dyphylline—ADORA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000136	0.000163	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—EGF—pancreatic cancer	0.000135	0.000162	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—HES1—pancreatic cancer	0.000134	0.000161	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—PIK3CG—pancreatic cancer	0.000133	0.00016	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—NRAS—pancreatic cancer	0.000133	0.00016	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000132	0.000159	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—EGF—pancreatic cancer	0.000131	0.000158	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000131	0.000157	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—EGFR—pancreatic cancer	0.000131	0.000157	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—NFKBIA—pancreatic cancer	0.000131	0.000157	CbGpPWpGaD
Dyphylline—PDE4C—Signaling by GPCR—PIK3CA—pancreatic cancer	0.00013	0.000157	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—NOTCH1—pancreatic cancer	0.000129	0.000155	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—KRAS—pancreatic cancer	0.000129	0.000155	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000128	0.000154	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000128	0.000154	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—NRAS—pancreatic cancer	0.000128	0.000154	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—PIK3CA—pancreatic cancer	0.000127	0.000153	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—EGF—pancreatic cancer	0.000127	0.000152	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—PIK3CG—pancreatic cancer	0.000126	0.000152	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—NRAS—pancreatic cancer	0.000126	0.000152	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—PIK3CB—pancreatic cancer	0.000126	0.000152	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—PIK3CD—pancreatic cancer	0.000126	0.000152	CbGpPWpGaD
Dyphylline—PDE4D—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000125	0.00015	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—EGF—pancreatic cancer	0.000125	0.00015	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—EGFR—pancreatic cancer	0.000125	0.00015	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—KRAS—pancreatic cancer	0.000124	0.000148	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—CXCL8—pancreatic cancer	0.000123	0.000148	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—TP53—pancreatic cancer	0.000123	0.000148	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—CXCL8—pancreatic cancer	0.000121	0.000146	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—EGFR—pancreatic cancer	0.000121	0.000146	CbGpPWpGaD
Dyphylline—PDE4C—Signaling by GPCR—HRAS—pancreatic cancer	0.000121	0.000145	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—PIK3CD—pancreatic cancer	0.00012	0.000144	CbGpPWpGaD
Dyphylline—PDE4A—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000119	0.000143	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—PIK3CA—pancreatic cancer	0.000118	0.000142	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—HRAS—pancreatic cancer	0.000118	0.000141	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—KRAS—pancreatic cancer	0.000118	0.000141	CbGpPWpGaD
Dyphylline—PDE4C—GPCR downstream signaling—AKT1—pancreatic cancer	0.000117	0.000141	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—TERT—pancreatic cancer	0.000117	0.000141	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—PIK3CD—pancreatic cancer	0.000117	0.00014	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—EGFR—pancreatic cancer	0.000117	0.00014	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—CASP3—pancreatic cancer	0.000116	0.00014	CbGpPWpGaD
Dyphylline—PDE3A—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000116	0.000139	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—EGFR—pancreatic cancer	0.000115	0.000138	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—KRAS—pancreatic cancer	0.000114	0.000137	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—TP53—pancreatic cancer	0.000114	0.000137	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000114	0.000136	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—CCND1—pancreatic cancer	0.000113	0.000136	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000113	0.000135	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—HIF1A—pancreatic cancer	0.000112	0.000135	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—CTNNB1—pancreatic cancer	0.000112	0.000135	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—TSC2—pancreatic cancer	0.000112	0.000134	CbGpPWpGaD
Dyphylline—ADORA1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000111	0.000134	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—PIK3CD—pancreatic cancer	0.000111	0.000134	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—KRAS—pancreatic cancer	0.00011	0.000132	CbGpPWpGaD
Dyphylline—PDE4B—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.00011	0.000132	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—PIK3CB—pancreatic cancer	0.00011	0.000132	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—MMP9—pancreatic cancer	0.00011	0.000132	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—APOE—pancreatic cancer	0.000109	0.000132	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—HRAS—pancreatic cancer	0.000109	0.000131	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—PTEN—pancreatic cancer	0.000109	0.000131	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—KRAS—pancreatic cancer	0.000109	0.000131	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000108	0.00013	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—KDR—pancreatic cancer	0.000107	0.000129	CbGpPWpGaD
Dyphylline—PDE4C—Signaling by GPCR—AKT1—pancreatic cancer	0.000107	0.000128	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—CXCL8—pancreatic cancer	0.000106	0.000127	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000105	0.000126	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—HRAS—pancreatic cancer	0.000105	0.000126	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—PIK3CB—pancreatic cancer	0.000105	0.000126	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—AKT1—pancreatic cancer	0.000104	0.000125	CbGpPWpGaD
Dyphylline—PDE4D—GPCR downstream signaling—AKT1—pancreatic cancer	0.000102	0.000123	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000102	0.000123	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—PIK3CB—pancreatic cancer	0.000102	0.000122	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—SRC—pancreatic cancer	0.000101	0.000122	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000101	0.000122	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—CASP3—pancreatic cancer	0.000101	0.000122	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—NOTCH1—pancreatic cancer	0.000101	0.000121	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—CXCL8—pancreatic cancer	0.000101	0.000121	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—PIK3CA—pancreatic cancer	0.0001	0.00012	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—HRAS—pancreatic cancer	0.0001	0.00012	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—PIK3CG—pancreatic cancer	9.88e-05	0.000119	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—NRAS—pancreatic cancer	9.88e-05	0.000119	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—VEGFA—pancreatic cancer	9.86e-05	0.000119	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—CCND1—pancreatic cancer	9.85e-05	0.000118	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—PIK3CB—pancreatic cancer	9.81e-05	0.000118	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—CXCL8—pancreatic cancer	9.79e-05	0.000118	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—EGF—pancreatic cancer	9.77e-05	0.000117	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—STAT3—pancreatic cancer	9.77e-05	0.000117	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—CTNNB1—pancreatic cancer	9.75e-05	0.000117	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—NRAS—pancreatic cancer	9.74e-05	0.000117	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—HRAS—pancreatic cancer	9.73e-05	0.000117	CbGpPWpGaD
Dyphylline—PDE4A—GPCR downstream signaling—AKT1—pancreatic cancer	9.72e-05	0.000117	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—PIK3CB—pancreatic cancer	9.69e-05	0.000116	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—AKT1—pancreatic cancer	9.66e-05	0.000116	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—CASP3—pancreatic cancer	9.63e-05	0.000116	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—MMP9—pancreatic cancer	9.56e-05	0.000115	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—PTEN—pancreatic cancer	9.51e-05	0.000114	CbGpPWpGaD
Dyphylline—PDE3A—GPCR downstream signaling—AKT1—pancreatic cancer	9.46e-05	0.000114	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—CXCL8—pancreatic cancer	9.42e-05	0.000113	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—CCND1—pancreatic cancer	9.38e-05	0.000113	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—CASP3—pancreatic cancer	9.37e-05	0.000113	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—HRAS—pancreatic cancer	9.36e-05	0.000112	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—CXCL8—pancreatic cancer	9.31e-05	0.000112	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—CTNNB1—pancreatic cancer	9.29e-05	0.000112	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—AKT1—pancreatic cancer	9.28e-05	0.000111	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—HRAS—pancreatic cancer	9.25e-05	0.000111	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—CCND1—pancreatic cancer	9.12e-05	0.00011	CbGpPWpGaD
Dyphylline—ADORA1—GPCR downstream signaling—AKT1—pancreatic cancer	9.1e-05	0.000109	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—MMP9—pancreatic cancer	9.1e-05	0.000109	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—MYC—pancreatic cancer	9.08e-05	0.000109	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—TGFB1—pancreatic cancer	9.05e-05	0.000109	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—PTEN—pancreatic cancer	9.05e-05	0.000109	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—CTNNB1—pancreatic cancer	9.03e-05	0.000109	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—CASP3—pancreatic cancer	9.02e-05	0.000108	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—EGFR—pancreatic cancer	9e-05	0.000108	CbGpPWpGaD
Dyphylline—PDE4B—GPCR downstream signaling—AKT1—pancreatic cancer	9e-05	0.000108	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—CASP3—pancreatic cancer	8.91e-05	0.000107	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—EGFR—pancreatic cancer	8.88e-05	0.000107	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—MMP9—pancreatic cancer	8.86e-05	0.000106	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—AKT1—pancreatic cancer	8.83e-05	0.000106	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—SRC—pancreatic cancer	8.82e-05	0.000106	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—PTEN—pancreatic cancer	8.8e-05	0.000106	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—CCND1—pancreatic cancer	8.78e-05	0.000105	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—CTNNB1—pancreatic cancer	8.69e-05	0.000104	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—PIK3CD—pancreatic cancer	8.69e-05	0.000104	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—CCND1—pancreatic cancer	8.68e-05	0.000104	CbGpPWpGaD
Dyphylline—ADORA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.6e-05	0.000103	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—CTNNB1—pancreatic cancer	8.59e-05	0.000103	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—AKT1—pancreatic cancer	8.59e-05	0.000103	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—VEGFA—pancreatic cancer	8.59e-05	0.000103	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—MMP9—pancreatic cancer	8.52e-05	0.000102	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—KRAS—pancreatic cancer	8.5e-05	0.000102	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—STAT3—pancreatic cancer	8.5e-05	0.000102	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—NRAS—pancreatic cancer	8.48e-05	0.000102	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—PTEN—pancreatic cancer	8.47e-05	0.000102	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—MMP9—pancreatic cancer	8.42e-05	0.000101	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—SRC—pancreatic cancer	8.39e-05	0.000101	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—KRAS—pancreatic cancer	8.39e-05	0.000101	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—PTEN—pancreatic cancer	8.37e-05	0.000101	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—AKT1—pancreatic cancer	8.27e-05	9.93e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—VEGFA—pancreatic cancer	8.17e-05	9.82e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—AKT1—pancreatic cancer	8.17e-05	9.82e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—SRC—pancreatic cancer	8.16e-05	9.81e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—STAT3—pancreatic cancer	8.09e-05	9.72e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—NRAS—pancreatic cancer	8.07e-05	9.7e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—VEGFA—pancreatic cancer	7.95e-05	9.55e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—MYC—pancreatic cancer	7.9e-05	9.49e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—TGFB1—pancreatic cancer	7.88e-05	9.47e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—STAT3—pancreatic cancer	7.87e-05	9.46e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—SRC—pancreatic cancer	7.86e-05	9.44e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—NRAS—pancreatic cancer	7.85e-05	9.44e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	7.81e-05	9.39e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—SRC—pancreatic cancer	7.77e-05	9.33e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—EGFR—pancreatic cancer	7.73e-05	9.29e-05	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—PIK3CA—pancreatic cancer	7.7e-05	9.26e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—VEGFA—pancreatic cancer	7.65e-05	9.2e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—STAT3—pancreatic cancer	7.58e-05	9.11e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—PIK3CB—pancreatic cancer	7.57e-05	9.1e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—VEGFA—pancreatic cancer	7.56e-05	9.09e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—NRAS—pancreatic cancer	7.56e-05	9.08e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—MYC—pancreatic cancer	7.52e-05	9.04e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—TGFB1—pancreatic cancer	7.5e-05	9.01e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—STAT3—pancreatic cancer	7.49e-05	9e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—NRAS—pancreatic cancer	7.47e-05	8.98e-05	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—TP53—pancreatic cancer	7.45e-05	8.96e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—EGFR—pancreatic cancer	7.36e-05	8.84e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—MYC—pancreatic cancer	7.32e-05	8.79e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—KRAS—pancreatic cancer	7.3e-05	8.77e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—TGFB1—pancreatic cancer	7.3e-05	8.77e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—CXCL8—pancreatic cancer	7.28e-05	8.74e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—HRAS—pancreatic cancer	7.23e-05	8.69e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—EGFR—pancreatic cancer	7.16e-05	8.6e-05	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—HRAS—pancreatic cancer	7.13e-05	8.57e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—MYC—pancreatic cancer	7.04e-05	8.46e-05	CbGpPWpGaD
Dyphylline—ADORA2A—GPCR downstream signaling—AKT1—pancreatic cancer	7.03e-05	8.45e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—TGFB1—pancreatic cancer	7.03e-05	8.44e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—CASP3—pancreatic cancer	6.96e-05	8.37e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—MYC—pancreatic cancer	6.96e-05	8.36e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—KRAS—pancreatic cancer	6.95e-05	8.35e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—TGFB1—pancreatic cancer	6.94e-05	8.34e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—EGFR—pancreatic cancer	6.89e-05	8.28e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—EGFR—pancreatic cancer	6.81e-05	8.18e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—CCND1—pancreatic cancer	6.78e-05	8.14e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—KRAS—pancreatic cancer	6.76e-05	8.12e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—CTNNB1—pancreatic cancer	6.71e-05	8.07e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—PIK3CA—pancreatic cancer	6.71e-05	8.06e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—MMP9—pancreatic cancer	6.58e-05	7.91e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—PTEN—pancreatic cancer	6.54e-05	7.86e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—KRAS—pancreatic cancer	6.51e-05	7.82e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—TP53—pancreatic cancer	6.49e-05	7.8e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—KRAS—pancreatic cancer	6.43e-05	7.73e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—PIK3CA—pancreatic cancer	6.38e-05	7.67e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—AKT1—pancreatic cancer	6.38e-05	7.67e-05	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—AKT1—pancreatic cancer	6.29e-05	7.56e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—PIK3CA—pancreatic cancer	6.21e-05	7.46e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—HRAS—pancreatic cancer	6.21e-05	7.46e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—TP53—pancreatic cancer	6.18e-05	7.42e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—SRC—pancreatic cancer	6.07e-05	7.29e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—TP53—pancreatic cancer	6.01e-05	7.22e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—PIK3CA—pancreatic cancer	5.98e-05	7.18e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—VEGFA—pancreatic cancer	5.91e-05	7.1e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—PIK3CA—pancreatic cancer	5.91e-05	7.1e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—HRAS—pancreatic cancer	5.91e-05	7.1e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—STAT3—pancreatic cancer	5.85e-05	7.03e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—NRAS—pancreatic cancer	5.84e-05	7.01e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—TP53—pancreatic cancer	5.78e-05	6.95e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—HRAS—pancreatic cancer	5.75e-05	6.9e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—TP53—pancreatic cancer	5.71e-05	6.87e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—HRAS—pancreatic cancer	5.53e-05	6.65e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—AKT1—pancreatic cancer	5.48e-05	6.58e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—HRAS—pancreatic cancer	5.47e-05	6.57e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—MYC—pancreatic cancer	5.44e-05	6.53e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—TGFB1—pancreatic cancer	5.42e-05	6.52e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—EGFR—pancreatic cancer	5.32e-05	6.39e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—AKT1—pancreatic cancer	5.22e-05	6.27e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—AKT1—pancreatic cancer	5.07e-05	6.1e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—KRAS—pancreatic cancer	5.02e-05	6.04e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—AKT1—pancreatic cancer	4.88e-05	5.87e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—AKT1—pancreatic cancer	4.83e-05	5.8e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—PIK3CA—pancreatic cancer	4.62e-05	5.55e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—TP53—pancreatic cancer	4.47e-05	5.37e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—HRAS—pancreatic cancer	4.27e-05	5.13e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—AKT1—pancreatic cancer	3.77e-05	4.53e-05	CbGpPWpGaD
